Development of a robust armoured RNA standard for the rapid clinical diagnosis of COVID-19
COVID-19, the respiratory disease caused by the novel SARS corona virus, has been a global threat for months now. The pandemic has crippled global healthcare sectors and economies. Early, rapid, and accurate detection of the contagion is critical for isolating infected patients to prevent further community spread. Currently, most communities in Canada suffer from insufficient testing capabilities, and as the need for testing increases, the added volume will produce a proportional amount of unreliable results. In collaboration with SM Research Inc (Mississauga, Ontario), an economical testing standard will be designed and produced to validate all COVID-19 diagnostic testing moving forward.